Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services.

Research output: Contribution to journalArticle

Abstract

Biotechnology products offer both problems and opportunities for pharmacists. On one hand, they are expensive to purchase and keep on inventory. Typical compensation for outpatient prescriptions does not offset the cost of maintaining the inventory, or providing the education and training that patients often need to use biotechnology products properly. On the other hand, there are issues related to proper storage, preparation, and administration for which pharmacists are well prepared to address. Pharmacists are also convenient, trusted, and provide service at relatively low cost. Examples of special services that pharmacists can provide to improve the use of biotechnology products include patient education, injection clinics, provision of medical supplies, and predrawing syringes for patients. Patients are often sent to many providers for these services, resulting in inconvenience and fragmentation of care. If new compensation methods can be established to support more comprehensive pharmacy services, the use of biotechnology products by patients will improve.

Original languageEnglish (US)
Pages (from-to)32-36
Number of pages5
JournalPharmacy practice management quarterly
Volume18
Issue number2
StatePublished - 1998
Externally publishedYes

Fingerprint

Pharmaceutical Services
Biotechnology
Pharmacists
Patient Education
Compensation and Redress
Costs and Cost Analysis
Equipment and Supplies
Syringes
Prescriptions
Outpatients
Injections

Cite this

@article{7986a8aa4ea34e4e885c34c3185000ff,
title = "Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services.",
abstract = "Biotechnology products offer both problems and opportunities for pharmacists. On one hand, they are expensive to purchase and keep on inventory. Typical compensation for outpatient prescriptions does not offset the cost of maintaining the inventory, or providing the education and training that patients often need to use biotechnology products properly. On the other hand, there are issues related to proper storage, preparation, and administration for which pharmacists are well prepared to address. Pharmacists are also convenient, trusted, and provide service at relatively low cost. Examples of special services that pharmacists can provide to improve the use of biotechnology products include patient education, injection clinics, provision of medical supplies, and predrawing syringes for patients. Patients are often sent to many providers for these services, resulting in inconvenience and fragmentation of care. If new compensation methods can be established to support more comprehensive pharmacy services, the use of biotechnology products by patients will improve.",
author = "Schneider, {Philip J}",
year = "1998",
language = "English (US)",
volume = "18",
pages = "32--36",
journal = "Pharmacy practice management quarterly",
issn = "1080-5737",
publisher = "Aspen Publishers Inc.",
number = "2",

}

TY - JOUR

T1 - Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services.

AU - Schneider, Philip J

PY - 1998

Y1 - 1998

N2 - Biotechnology products offer both problems and opportunities for pharmacists. On one hand, they are expensive to purchase and keep on inventory. Typical compensation for outpatient prescriptions does not offset the cost of maintaining the inventory, or providing the education and training that patients often need to use biotechnology products properly. On the other hand, there are issues related to proper storage, preparation, and administration for which pharmacists are well prepared to address. Pharmacists are also convenient, trusted, and provide service at relatively low cost. Examples of special services that pharmacists can provide to improve the use of biotechnology products include patient education, injection clinics, provision of medical supplies, and predrawing syringes for patients. Patients are often sent to many providers for these services, resulting in inconvenience and fragmentation of care. If new compensation methods can be established to support more comprehensive pharmacy services, the use of biotechnology products by patients will improve.

AB - Biotechnology products offer both problems and opportunities for pharmacists. On one hand, they are expensive to purchase and keep on inventory. Typical compensation for outpatient prescriptions does not offset the cost of maintaining the inventory, or providing the education and training that patients often need to use biotechnology products properly. On the other hand, there are issues related to proper storage, preparation, and administration for which pharmacists are well prepared to address. Pharmacists are also convenient, trusted, and provide service at relatively low cost. Examples of special services that pharmacists can provide to improve the use of biotechnology products include patient education, injection clinics, provision of medical supplies, and predrawing syringes for patients. Patients are often sent to many providers for these services, resulting in inconvenience and fragmentation of care. If new compensation methods can be established to support more comprehensive pharmacy services, the use of biotechnology products by patients will improve.

UR - http://www.scopus.com/inward/record.url?scp=0032111592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032111592&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 32

EP - 36

JO - Pharmacy practice management quarterly

JF - Pharmacy practice management quarterly

SN - 1080-5737

IS - 2

ER -